Dataset Information

Long-term adaptation of lymphoma cells to hypoxia is mediated by diverse molecular mechanisms that are targetable with specific inhibitors

ABSTRACT: In this study we analyzed impact of long-term hypoxia on a panel of lymphoma cell lines. Only 2 out of 8 tested lymphoma cell lines (Ramos, and HBL2) survived > 4 weeks under deep hypoxia (1% O2). The hypoxia-adapted (HA) Ramos and HBL2 cells had severely decreased proliferation rate accompanied by complex changes of the transcriptome, proteome, and metabolome. Seahorse analysis demonstrated near complete blockage of both oxidative phosphorylation and glycolytic pathways. Both transcriptome and proteome analyses showed significant downregulation of mitochondrial respiration complexes I and IV, many mitochondrial ribosomal proteins, and increase of proteins regulating glycolysis and mitophagy. Both HA cell lines had an increased total mitochondrial mass, but a decreased mitochondrial DNA content compared to normoxic controls. Sensitivity of HA cells to 2-deoxyglucose, an inhibitor of glycolysis, and to A1155463, a BCL-XL inhibitor were, was markedly increased. Indeed, co-culture on CD40 ligand expressing fibroblasts (that induce BCL-XL expression) significantly increased survival of lymphoma cells under hypoxia. Of note, prolyl hydroxylase P4HA1 involved in the stabilization of hypoxia-induced factor (HIF) 1 alpha was increased in both HA cell lines on both mRNA and protein levels. Transgenic (over)expression of P4HA1 in hypoxia-sensitive MINO cells was associated with increased survival under hypoxia. Our data suggest that under long-term hypoxia, lymphoma cells try to compensate for the decrease in ATP production from the oxidative phosphorylation process by boosting structural machinery of glycolysis, as well as amino-acid recycling by mitophagy, on which they become vitally dependent for survival, and which can be targeted by specific inhibitors. The data also suggest increased dependence of lymphoma cells on BCL-XL under hypoxia. Finally, P4HA1 plausibly represents a novel druggable target for more effective elimination of hypoxia-adapted lymphoma cells.

ORGANISM(S): Homo sapiens

PROVIDER: GSE266442 | GEO | 2025/07/01

REPOSITORIES: GEO

ACCESS DATA

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Project description:Radiotherapy has a critical role in the treatment of small cell lung cancer (SCLC). Effectiveness of radiation in SCLC remains limited as resistance results from defects in apoptosis. In the current study, we investigated whether using a Bcl-2/Bcl-XL inhibitor S44563 can enhance radiosensitivity of SCLC cells in vitro and in vivo. In vitro studies confirmed that S44563 induce apoptosis in SCLC cells by inducing hallmarks of apoptosis (cleaved caspase-3, sub-G1 fraction induction and induction of the mitochondrial caspase activation pathway). S44563 markedly enhanced sensitivity of H146 cells and H69 cells to radiation in clonogenic assay. In addition, the combination S44563 and cisplatin-based chemo-radiation showed a dramatic tumor growth delay and increased overall survival in mouse xenograft models. In vitro experiments demonstrated a greater induction of apoptosis (sub-G1 fraction and cleaved caspase-3) with the combination as well as in vivo caspase-3 immunostaining. This positive interaction between S44563 and radiation was greater when S44563 was given after the completion of the radiation, which may be explained by the radiation-induced over expression of anti-apoptotic proteins (Bcl-2 and Bcl-XL) through the NF-?B pathway activation. Taken together, these data underline the critical role of sequence administration of targeted therapies with conventional therapies. SCLC cells which survive to IR highly rely on the induction of anti apoptotic proteins in part through NF- ?B activation for their survival yielding to the concept of 'contextual oncogene addiction' to the Bcl-2/Bcl-XL pathway providing rational for targeting survival pathways to potentiate IR. For transcriptome analysis, 106 cells were seeded in T25 flasks, allowed to growth for 24 h, and then left untreated or treated with 2 Gy radiation. After 24 hours, cells were harvested, lysed for the extraction of RNA, and processed to analyze gene expression.The design of this study consists to 6 hybridizations in dual color with Agilent Human Genome 4x44K (design 014850). The reference is always the untreated condition.

Dataset Information

Long-term adaptation of lymphoma cells to hypoxia is mediated by diverse molecular mechanisms that are targetable with specific inhibitors

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets